Live Breaking News & Updates on Wayne Lautt

Stay updated with breaking news from Wayne lautt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SciMar seeks U.S. retail investors amid cash crunch – Winnipeg Free Press

SciMar seeks U.S. retail investors amid cash crunch – Winnipeg Free Press
winnipegfreepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from winnipegfreepress.com Daily Mail and Mail on Sunday newspapers.

Winnipeg , Manitoba , Canada , Andrea-ladouceur , Wayne-lautt , Joelle-foster , Martin-cash , Mick-lautt , John-west , Forge-technology-exchange , Scimar-ltd , Winnipeg-free-press-newsletter

DMAC Stock Price | Diamedica Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

DMAC | Complete Diamedica Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ....

Diamedica-therapeutics-inc , Diamedica-therapeutics , Medica-therapeutics , Wayne-lautt ,

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Drops By 5.6%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totalling 91,900 shares, a drop of 5.6% from the April 15th total of 97,400 shares. Based on an average daily trading volume, of 27,100 shares, the days-to-cover ratio […] ....

Davidj-wambeke , Catalyst-financial-partners , Securities-exchange-commission , Renaissance-technologies , Citadel-advisors , Diamedica-therapeutics-inc , Nasdaq , Diamedica-therapeutics , Get-rating , Medica-therapeutics-trading-down , Medica-therapeutics

Head-To-Head Analysis: Marinus Pharmaceuticals (NASDAQ:MRNS) & DiaMedica Therapeutics (NASDAQ:DMAC)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and Marinus Pharmaceuticals (NASDAQ:MRNS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation. Volatility and Risk DiaMedica Therapeutics has a beta of […] ....

Marinus-pharmaceuticals , Diamedica-therapeutics-inc , Marinus-pharmaceuticals-inc , Diamedica-therapeutics , Get-rating , Medica-therapeutics , Marinus-pharmaceutical , Given-diamedica-therapeutic , Wayne-lautt , Diamedica-therapeutics-daily , Nasdaq-dmac